Published

Use of AstraZeneca’s vaccine paused

The Public Health Agency of Sweden has decided that the use of AstraZeneca’s Covid-19 vaccine should be paused until the European Medicines Agency’s investigation of suspected side effects is complete.

The European Medicines Agency (EMA) and the Swedish Medical Products Agency are investigating suspected side effects of blood clots and bleeding in people vaccinated with AstraZeneca’s Covid-19 vaccine in order to determine whether there is a causal link with the vaccine.

The purpose of the investigation is to ensure that the vaccine is safe.

"We have a good understanding of the vaccine, but it is still important that we pause vaccinations until EMA has investigated whether these events may be related to vaccination," says Anders Tegnell.

If you have recently been vaccinated with vaccine from Astra Zeneca:

Pay attention to bruising or pinpoint bleeding in the skin, nosebleeds, or swelling, redness or pronounced tenderness in the legs or arms. You do not need to contact a healthcare specialist if you do not have any of these symptoms.

If any of these symptoms occur, call 1177 Vårdguiden where a registered nurse will help. Tell them that you have recently been vaccinated. If you feel acutely ill, call 112 for an ambulance.